Latest Breaking News On - Theralink technologies - Page 7 : comparemela.com

Theralink® Technologies Achieves the First College of American Pathologists Accreditation for a Commercial Reverse Phase Protein Array Laboratory in U S

Theralink® Technologies Achieves the First College of American Pathologists Accreditation for a Commercial Reverse Phase Protein Array Laboratory in U S
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMick ruxinTheralink technologieExchange commissionCollege of american pathologistsTheralink technologies incCollege of america pathologistsAmerican pathologistsAccreditation signifiesHighest standardsReverse phase protein arrayAccreditation committeeNext generation proteomicAmerica pathologistsTheralink technologiesInc theralink technologies

Theralink® Technologies Appoints Dr Mattia Cremona as its Director of its Biopharma Laboratory

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay.

United statesUnited kingdomMick ruxinMattia cremonaBiopharma laboratoryTheralink technologies incGeorge mason universitySeasoned cancer researchPhase protein array technologyRoyal college of surgeonsSeasoned cancer research fellowReverse phase protein array technologyTheralink technologiesResearch fellowRoyal collegeReverse phase protein array

Theralink® Acquires Two New Milestone Patents Relating to Methods for Treating Breast Cancer

/PRNewswire/ Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein-based assay.

United statesEmanuel petricoinMick ruxinGeorge mason universityTheralink technologies incPhase protein array technologyPredictive biomarker patentsBreast cancerTheralink technologiesScience advisory boardReverse phase protein array technologyTheralink assayPatent detailsTreating breast cancerReverse phase protein array

Theralink® Technologies to Host Fireside Chat with Dr Mick Ruxin, President and Chief Executive Officer, on June 22nd at 11:00 a m ET

/PRNewswire/ Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision medicine company with a novel phosphoprotein-based assay for.

United statesMick ruxinStrategic communicationsTheralink technologies incTheralink technologiesReverse phase protein array

Theralink® Technologies Expands Adoption of its Precision Medicine Technology in the Biopharmaceutical Industry

/PRNewswire/ Theralink Technologies (OTC: THER) ("Theralink" or the "Company"), a precision medicine company with a novel phosphoprotein-based assay for.

United statesMick ruxinTheralink technologies incCompanion diagnosticsLaser capture microdissectionReverse phase protein arrayTheralink technologies